tiprankstipranks
Trending News
More News >
Omega Diagnostics Group PLC (GB:CNSL)
LSE:CNSL
Advertisement

Omega Diagnostics (CNSL) Price & Analysis

Compare
3 Followers

CNSL Stock Chart & Stats


Omega Diagnostics News

CNSL FAQ

What was Omega Diagnostics Group PLC’s price range in the past 12 months?
Omega Diagnostics Group PLC lowest share price was 2.42p and its highest was 4.38p in the past 12 months.
    What is Omega Diagnostics Group PLC’s market cap?
    Omega Diagnostics Group PLC’s market cap is £7.73M.
      When is Omega Diagnostics Group PLC’s upcoming earnings report date?
      Omega Diagnostics Group PLC’s upcoming earnings report date is Nov 20, 2025 which is in 82 days.
        How were Omega Diagnostics Group PLC’s earnings last quarter?
        Omega Diagnostics Group PLC released its earnings results on Aug 19, 2025. The company reported 0p earnings per share for the quarter, beating the consensus estimate of -0.001p by 0.001p.
          Is Omega Diagnostics Group PLC overvalued?
          According to Wall Street analysts Omega Diagnostics Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Omega Diagnostics Group PLC pay dividends?
            Omega Diagnostics Group PLC does not currently pay dividends.
            What is Omega Diagnostics Group PLC’s EPS estimate?
            Omega Diagnostics Group PLC’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Omega Diagnostics Group PLC have?
            Omega Diagnostics Group PLC has 237,950,650 shares outstanding.
              What happened to Omega Diagnostics Group PLC’s price movement after its last earnings report?
              Omega Diagnostics Group PLC reported an EPS of 0p in its last earnings report, beating expectations of -0.001p. Following the earnings report the stock price went down -5.714%.
                Which hedge fund is a major shareholder of Omega Diagnostics Group PLC?
                Currently, no hedge funds are holding shares in GB:CNSL

                Company Description

                Omega Diagnostics Group PLC

                Cambridge Nutritional Sciences plc, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the Foodprint name. It provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The company serves government, private hospitals, reference laboratories, nutritionists, naturopaths, and other healthcare professionals. Cambridge Nutritional Sciences plc operates in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc was founded in 1987 and is based in London, the United Kingdom.

                Omega Diagnostics (CNSL) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                RUA Life Sciences
                EKF Diagnostics Holdings
                Feedback
                Cizzle Biotechnology Holdings PLC
                Tristel

                Ownership Overview

                0.08%99.92%
                Mutual Funds
                ― Other Institutional Investors
                99.92% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis